Report Description

The Indonesia Over the Counter Drugs (OTC) Market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the expansion of self-medication culture. Indonesian consumers are becoming more proactive in managing their health and relying on self-medication practices. This has fueled the demand for OTC drugs for common ailments such as headaches, cold and flu symptoms, and digestive issues. Additionally, there is a growing emphasis on wellness among Indonesian consumers, leading to increased demand for OTC products focused on preventive healthcare, such as vitamins, dietary supplements, and natural remedies. Moreover, traditional herbal medicines have a long-standing presence in Indonesian culture, resulting in an increased market for OTC products derived from natural ingredients and traditional healing practices.

Consumers are seeking OTC products for skincare, hair care, oral care, and other personal care needs driven by a desire for self-care and enhanced appearance. The revenue of Indonesia Over the Counter Drugs Market is USD2287.00 million in 2023 and will register a CAGR of 6.12% in the forecast years. Furthermore, 17.9% of total revenue will come from e-Commerce sales.

Nonetheless, the COVID-19 pandemic has led to increased demand for specific OTC products. Items such as hand sanitizers, face masks, thermometers, cough, and immune-boosting supplements have experienced a surge in demand as consumers sought products for personal hygiene, symptom relief, and immune support. International companies are partnering or collaborating with government institutions and healthcare organizations to expand their market presence, as Indonesian consumers place high importance on brand reputation, quality, and trust. International companies are known for the same and have an advantage in gaining consumer trust and acceptance.

Increased Focus on Herbal and Traditional Medicine

Herbal and traditional medicines have a significant presence and influence in Indonesia. The country has a rich tradition of traditional healing practices and a deep cultural belief in the power of natural remedies. Traditional medicine, known as "jamu" in Indonesia, has been practiced for centuries. It involves the use of natural ingredients, such as herbs, roots, and spices, to promote health and treat various ailments.

The Indonesian government recognizes the importance of traditional medicine and has taken steps to support its development and integration into the healthcare system. The Ministry of Health has established regulations and guidelines to ensure the safety, quality, and efficacy of traditional medicines. There are numerous local companies in Indonesia specializing in the production and distribution of herbal and traditional medicines. These companies often have a strong focus on sourcing high-quality natural ingredients and adhering to traditional formulations while also incorporating modern manufacturing practices.

The National Agency of Drug and Food Control (BPOM) oversees the registration and regulation of traditional medicines in Indonesia. Traditional medicine products must go through a registration process to ensure their safety, quality, and adherence to specific standards. Many consumers prefer herbal remedies as an alternative or complementary approach to conventional medicine, particularly for common ailments and maintaining overall wellness.

Indonesian institutions and researchers are actively studying traditional medicinal plants to validate their efficacy, identify active compounds, and develop standardized extracts or formulations. This research contributes to the modernization and scientific understanding of traditional medicine practices.

Indonesia's rich biodiversity and traditional medicine practices present export opportunities for herbal and traditional medicine products. The demand for Indonesian traditional medicines has expanded beyond domestic borders, and there is growing interest from international markets. This factor will help in the growth of the Indonesia Over the Counter Drugs Market.

Expansion of Self Medication Culture

Indonesia has witnessed an expansion of self-medication culture in recent years. Self-medication refers to the practice of individuals treating minor ailments or managing their health conditions without consulting a healthcare professional. With greater access to information through the internet and other sources, individuals are more informed about common health conditions, symptoms, and available treatment options. This has contributed to a rise in self-medication practices. The availability of a wide range of OTC drugs in pharmacies and retail outlets has facilitated self-medication in Indonesia. Consumers can easily access medications without a prescription for common ailments such as headaches, colds, allergies, and digestive issues. Self-medication is often driven by affordability and convenience. OTC drugs are generally more affordable compared to prescription medications and do not require visits to healthcare professionals, saving time and costs for consumers. Indonesian consumers tend to trust the efficacy of OTC drugs for managing minor health conditions. They rely on their own judgment and past experiences, as well as recommendations from family, friends, and pharmacists when selecting OTC medications. Self-medication often involves treating specific symptoms rather than diagnosing and addressing underlying health conditions. Consumers may choose OTC drugs that provide relief for symptoms they are experiencing. Pharmacists play a crucial role in facilitating self-medication practices in Indonesia. They are trained professionals who can provide advice, recommendations, and information about OTC drugs, ensuring responsible use and minimizing potential risks. This factor will accelerate the growth of Indonesia Over the Counter Drugs Market.

Growing Demand for Wellness and Beauty Products

Consumers are becoming more conscious of personal well-being, self-care, and appearance, driving the growth of the market. Indonesian consumers are increasingly prioritizing self-care and wellness. They are seeking products that promote overall well-being, enhance vitality, and support a healthy lifestyle. The demand for OTC drugs in the skincare and personal care has seen significant growth. Consumers are increasingly looking for products that address specific skincare concerns, such as anti-aging, acne treatment, moisturization, and sun protection. OTC skincare products, including creams, lotions, serums, and masks, are popular choices. The market for OTC hair care products, including shampoos, conditioners, hair masks, and styling products, is expanding in Indonesia. Consumers are seeking products that cater to their specific hair care needs, such as repairing damaged hair, addressing hair loss, and enhancing hair volume and shine. Oral care products, such as toothpaste, mouthwash, and dental floss, are witnessing increased demand as consumers become more conscious of dental hygiene and oral health. Products that offer teeth whitening, fresh breath, and cavity protection are particularly sought after. Social media platforms play a significant role in shaping consumer preferences and driving demand for wellness and beauty OTC products. Influencers and online beauty communities share product recommendations, skincare routines, and beauty tips, influencing consumer choices and contributing to the growth of the market. This factor will help in the increment of Indonesia over the Counter Drugs Market.

Recent Developments

In 2022, PT Kalbe Farma Tbk or Kalbe, through its subsidiary KALGen Innolab, launched Nutrigenme Life, the latest genetic assessment that can analyze DNA variations associated with an individual's lifestyle habits.

In 2023, PT Kalbe Farma Tbk, through KALGen Innolab (the Kalbe Genomics Laboratory), is collaborating with Roche and its subsidiary, Foundation Medicine Inc. or FMI, to launch an assessment service called Comprehensive Genomic Profiling (CGP) with Advanced Sequencing (NGS) technology.

Market Segmentation

Indonesia Over the Counter Drugs (OTC) Market can be segmented by product type, by route of administration, by dosage form, by distribution channel, by end user, and by region and competitive landscape. The Indonesia Over the Counter Drugs (OTC) Market can be categorized by Product Type into Cough, Cold and Flu; Vitamins, Mineral, and Supplements (VMS); Analgesics; Gastrointestinal Products; Dermatology Products; and Others. It can also be segmented by Route of Administration into Oral, Topical, and Parenteral. Additionally, Dosage Form options include Tablets, Capsules, Liquid & Solutions, Creams/Lotions/Ointments, and Others. The Distribution Channel comprises Retail Pharmacy, Hospital Pharmacy, and E-Pharmacy. Furthermore, the End User segment consists of Adults, Geriatric, Pregnant Females, Children, and Infants. Lastly, the market can be analyzed by region, specifically Java, Sumatra, Kalimantan, Bali and others.

Market Players

PT Kalbe Farma Tbk, PT Kimia Farma Tbk, PT Tempo Scan Pacific Tbk, PT Sanbe Farma, PT Phapros Tbk, Johnson & Johnson Indonesia PT, GlaxoSmithKline Indonesia PT, PT. Bayer Indonesia are some of the players in Indonesia Over the Counter Drugs (OTC) Market.

 

Download Free Sample Report

Attribute

Details

Base Year

2022

Historic Data

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million, and CAGR for 2018-2022 and 2023E-2028F

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

Product Type

Route of Administration

Dosage Form

Distribution Channel

End User

Regional scope

Java, Sumatra, Kalimantan, Bali, Others

Key companies profiled

PT Kalbe Farma Tbk, PT Kimia Farma Tbk, PT Tempo Scan Pacific Tbk, PT Sanbe Farma, PT Phapros Tbk, Johnson & Johnson Indonesia PT, GlaxoSmithKline Indonesia PT, PT. Bayer Indonesia

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

 Report Scope:

In this report, the Indonesia Over the Counter Drugs (OTC) Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Indonesia Over the Counter Drugs (OTC) Market, By Product Type:

o   Cough, Cold and Flu

o   Vitamins, Mineral, and Supplements (VMS)

o   Analgesics

o   Gastrointestinal Products

o   Dermatology Products

o   Others

  • Indonesia Over the Counter Drugs (OTC) Market, By Route of Administration:

                  o   Oral

o   Topical

o   Parenteral

  • Indonesia Over the Counter Drugs (OTC) Market, By Dosage Form:

                  o   Tablets

o   Capsules

o   Liquid & Solutions

o   Creams/Lotions/Ointments

o   Others

  • Indonesia Over the Counter Drugs (OTC) Market, By Distribution Channel:

                  o   Retail Pharmacy

o   Hospital Pharmacy

o   E-Pharmacy

  •  Indonesia Over the Counter Drugs (OTC) Market, By End User:

                  o   Adults

o   Geriatric

o   Pregnant Females

o   Children

o    Infants

  •  Indonesia Over the Counter Drugs (OTC) Market, By Region:

o      Java

o      Sumatra

o      Kalimantan

o      Bali

o      Others

 Competitive Landscape

Company Profiles: Detailed analysis of the major companies present Indonesia Over the Counter Drugs (OTC) Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Indonesia Over the Counter Drugs (OTC) Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.    Markets Covered

1.2.2.    Years Considered for Study

1.2.3.    Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Types

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, and Trends

4.    Voice of Customer

5.    Indonesia Over the Counter Drugs (OTC) Market Outlook:

5.1.  Market Size & Forecast

5.1.1.    By Value

5.2.  Market Share & Forecast

5.2.1.    By Product Type (Cough, Cold and Flu; Vitamins, Mineral, and Supplements (VMS); Analgesics; Gastrointestinal Products; Dermatology Products; Others)

5.2.2.    By Route of Administration (Oral, Topical, Parenteral)

5.2.3.    By Dosage Form (Tablets, Capsules, Liquid & Solutions, Creams/Lotions/Ointments, Others)

5.2.4.    By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)

5.2.5.    By End User (Adults, Geriatric, Pregnant Females, Children, Infants)

5.2.6.    By Region (Java, Sumatra, Kalimantan, Bali, Others)

6.    Indonesia Cough, Cold, Flu Over the Counter (OTC) Drugs Market Outlook:

6.1.  Market Size & Forecast       

6.1.1.    By Value

6.2.  Market Share & Forecast

6.2.1.    By Route of Administration

6.2.2.    By Dosage Form

6.2.3.    By Distribution Channel

6.2.4.    By End User

7.     Indonesia Vitamins, Mineral and Supplements (VMS) Over the Counter (OTC) Drugs Market Outlook:

7.1.  Market Size & Forecast       

7.1.1.    By Value

7.2.  Market Share & Forecast

7.2.1.    By Route of Administration

7.2.2.    By Dosage Form

7.2.3.    By Distribution Channel

7.2.4.    By End User

8.    Argentina Analgesics Over the Counter (OTC) Drugs Market Outlook:

 

8.1.  Market Size & Forecast      

         8.1.1   By Value

8.2.  Market Share & Forecast

     8.2.1. By Route of Administration

     8.2.2. By Dosage Form

     8.2.3.  By Distribution Channel

     8.2.4   By End User

9.  Argentina Gastrointestinal Over the Counter (OTC) Drugs Market Outlook:

9.1.  Market Size & Forecast      

       9.1.1. By Value

9.2.  Market Share & Forecast

      9.2.1.  By Route of Administration

      9.2.2.  By Dosage Form

      9.2.3.  By Distribution Channel

      9.2.4   By End User

10.  Argentina Dermatology Over the Counter (OTC) Drugs Market Outlook:

10.1.  Market Size & Forecast 

        10.1.1.  By Value

10.2.  Market Share & Forecast

       10.2.1.  By Route of Administration

       10.2.2.  By Dosage Forms

       10.2.3.  By Distribution Channel

 

9.    Market Dynamics

9.1.  Drivers

9.2.  Challenges

10. Market Trends & Developments

10.1.             Merger & Acquisition

10.2.             Product Development

10.3.             Recent Developments

11. Policy & Regulatory Landscape

12. Porters Five Forces Analysis

12.1.             Competition in the Industry

12.2.             Potential of New Entrants

12.3.             Power of Suppliers

12.4.             Power of Customers

12.5.             Threat of Substitute Products

13. India Economic Profile

14. Competitive Landscape

14.1.             Business Overview

14.2.             Company Snapshot

14.3.             Products & Services

14.4.             Financials (As Reported)

14.5.             Recent Developments

14.5.1. PT Kalbe Farma Tbk

14.5.2. PT Kimia Farma Tbk

14.5.3. PT Tempo Scan Pacific Tbk

14.5.4. PT Sanbe Farma

14.5.5. PT Phapros Tbk

14.5.6. Johnson & Johnson Indonesia PT

14.5.7. GlaxoSmithKline Indonesia PT

14.5.8. PT. Bayer Indonesia

15. Strategic Recommendations

About Us & Disclaimer

Figures and Tables

Frequently asked questions

down-arrow

Collaborating with local distributors, retailers, or pharmaceutical companies can provide international companies with valuable market insights, established distribution networks, and access to local expertise. Strategic partnerships can help navigate regulatory requirements, enhance market penetration, and build brand visibility.

down-arrow

The pandemic has resulted in a heightened demand for certain over the counter (OTC) products. Essential items such as hand sanitizers, face masks, thermometers, cough and cold medicines, and immune-boosting supplements have experienced a significant surge in demand, driven by consumers seeking products for personal hygiene, symptom relief, and immune support.

down-arrow

Several trends are shaping the Indonesian OTC drugs market which include expansion of self-medication culture, digitalization and e-commerce, focus on herbal and traditional medicines, increasing health consciousness and so on.

down-arrow

Companies operating in the OTC drugs market in Indonesia may face several challenges. Some of the major challenges include competition from traditional medicines, brand differentiation, language and cultural barriers, adapting to changing consumer preferences, market fragmentation and so on.

profile

Sakshi Bajaal

Business Consultant
Press Release

Indonesia Over the Counter (OTC) Drugs Market to be dominated by Analgesics through 2028

Sep, 2023

Increase in chronic diseases is expected to drive the growth of Indonesia Over the Counter (OTC) Drugs Market in the forecast period, 2024-2028